Simulations Plus, Inc. (SLP)
Market Cap | 285.20M |
Revenue (ttm) | 80.38M |
Net Income (ttm) | -63.19M |
Shares Out | 20.13M |
EPS (ttm) | -3.15 |
PE Ratio | n/a |
Forward PE | 47.23 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 190,720 |
Open | 14.23 |
Previous Close | 14.22 |
Day's Range | 13.93 - 14.36 |
52-Week Range | 12.39 - 37.67 |
Beta | 0.76 |
Analysts | Buy |
Price Target | 29.50 (+108.19%) |
Earnings Date | Oct 22, 2025 |
About SLP
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models,... [Read more]
Financial Performance
In 2024, Simulations Plus's revenue was $70.01 million, an increase of 17.52% compared to the previous year's $59.58 million. Earnings were $9.95 million, a decrease of -0.07%.
Financial StatementsAnalyst Summary
According to 7 analysts, the average rating for SLP stock is "Buy." The 12-month stock price target is $29.5, which is an increase of 108.19% from the latest price.
News

SLP SHAREHOLDERS: Simulations Plus, Inc. Investors may have been Affected by Fraud – Contact BFA Law if You Lost Money (NASDAQ:SLP)
NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the ...

Simulations Plus (SLP) Faces Investor Scrutiny After Asset Impairment and Auditor Firing-- Hagens Berman
SAN FRANCISCO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Hagens Berman has launched an investigation into Simulations Plus, Inc. (NASDAQ: SLP) after the company's stock price plummeted approximately 25% on Ju...

Simulations Plus to Participate in Upcoming Investor Conferences
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”, “SLP”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance an...

SLP INVESTOR NOTIFICATION: Simulations Plus, Inc. Investors are Urged to Contact BFA Law about the Pending Securities Fraud Investigation (NASDAQ:SLP)
NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the ...

Simulations Plus (SLP) Faces Investor Scrutiny After Asset Impairments and Grant Thornton Contests Company Statements About Dismissal -- Hagens Berman
SAN FRANCISCO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Investors in Simulations Plus, Inc. (NASDAQ: SLP) saw the price of their shares decline about 25% on July 15, 2025 after the company reported its Q3 20...

SLP CLASS REMINDER: Suffer Losses on Your Simulations Plus, Inc. Investment? Contact BFA Law about the Securities Fraud Investigation (NASDAQ:SLP)
NEW YORK, Aug. 23, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the ...

SLP SHAREHOLDER NOTICE: Simulations Plus, Inc. Investors are Notified of the Ongoing Securities Fraud Investigation -- Contact BFA Law if You Suffered Losses (NASDAQ:SLP)
NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the ...

SLP Investors Have Opportunity to Join Simulations Plus, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES , Aug. 21, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Simulations Plus, In...

SLP SECURITIES: Simulations Plus, Inc. Shareholders that Lost Money may have been Affected by Fraud -- Contact BFA Law (NASDAQ:SLP)
NEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the ...

SLP FRAUD REMINDER: Simulations Plus, Inc. Stock Drop Triggers Securities Fraud Investigation – Contact BFA Law if You Lost Money (NASDAQ:SLP)
NEW YORK, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the ...

SIMULATIONS PLUS STOCK: Lose Money on Your Simulations Plus, Inc. (NASDAQ:SLP) Investment? Contact BFA Law about its Securities Investigation
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the ...

Simulations Plus (SLP) Faces Investor Scrutiny After Asset Impairments and Grant Thornton Contests Company Statements About Dismissal – Hagens Berman
SAN FRANCISCO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Investors in Simulations Plus, Inc. (NASDAQ: SLP) saw the price of their shares decline about 25% on July 15, 2025 after the company reported its Q3 20...

SLP BREAKING INVESTIGATION: BFA Law Announces an Investigation into Simulations Plus, Inc. after Stock Plummets over 25% on Impairment Charges – Contact BFA Law if You Lost Money
NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of the ...

SLP BREAKING NEWS: Simulations Plus, Inc. Stock Significantly Declines After Impairment Charge and Auditor Departure -- Investors Urged to Contact BFA Law
NEW YORK--(BUSINESS WIRE)---- $SLP #Attorney--Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Simulations Plus, Inc. (NASDAQ: SLP) for potential violations of th...

Simulations Plus and the Institute of Medical Biology of the Polish Academy of Sciences Partnership Announces Results in Validation of ADMET Predictor® Models with Enhanced AI Drug Design
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intel...

Simulations Plus: Still Positioned For FDA In‑Silico Trend Despite Near‑Term Headwinds
Simulations Plus has recently declined after its Q3 2025 report, despite having a healthy revenue growth and adjusted EPS beat. This decline was mostly driven by a non‑cash impairment and lowered reve...

Simulations Plus Sees Weaker Demand Persist, Outlook Softens
Simulations Plus Inc. SLP shares declined on Tuesday following the release of its third-quarter 2025 earnings report.

Simulations Plus, FB Financial And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 100 points on Tuesday.

Simulations Plus, Inc. (SLP) Q3 2025 Earnings Call Transcript
Simulations Plus, Inc. (NASDAQ:SLP) Q3 2025 Earnings Conference Call July 14, 2025 5:00 PM ET Company Participants Shawn M. O'Connor - Chief Executive Officer William Frederick - EVP & CFO Conference...

Simulations Plus Invests in Clinical Development Technology Company Nurocor
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intel...

Simulations Plus Reports Third Quarter Fiscal 2025 Financial Results
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a leading provider of cheminformatics, biosimulation, simulation-enabled perf...

Simulations Plus Announces Rescheduling of Third Quarter Fiscal 2025 Earnings Release and Conference Call
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a leading provider of cheminformatics, biosimulation, simulation-enabled perf...

Simulations Plus: Further Downside Is Likely (Rating Downgrade)
Simulations Plus' Q3 FY25 results missed expectations, with revenue guidance cut sharply due to biopharma market weakness and services segment volatility. Organic growth continues to decelerate and th...

Simulations Plus Slashes Guidance Amid Biotech Spending Cuts, Analyst Expresses Doubt
Simulations Plus Inc SLP stock tanked after the company lowered its fiscal 2025 sales outlook.

Simulations Plus to Participate in the Citizens Medical Devices and Healthcare Services Forum
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”, “SLP”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance an...